Correspondence 0001628280-23-041622 from GRI Bio, Inc. (GRI)
GRI Bio, Inc.
Date: Dec. 14, 2023 · CIK: 0001824293 · Accession: 0001628280-23-041622
AI Filing Summary & Sentiment
File numbers found in text: 333-274972
Show Raw Text
CORRESP 1 filename1.htm Document GRI BIO, INC. 2223 AVENIDA DE LA PLAYA, SUITE 208 LA JOLLA, CA 92037 December 14, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Jimmy McNamara and Laura Crotty, Office of Life Sciences Re: GRI Bio, Inc. Registration Statement on Form S-3 Filed on October 13, 2023, as amended on Form S-1 File No. 333-274972 (the “Registration Statement”) Acceleration Request Ladies and Gentlemen: In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, GRI Bio, Inc. (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement to Friday, December 15, 2023, at 4:01p.m., Eastern Time, or as soon as thereafter practicable. The cooperation of the staff in meeting the timetable described above is very much appreciated. Please contact Melanie Ruthrauff Levy or Jason Miller of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (858) 314-1873 or (858) 314-2140, respectively, with any questions regarding this request. Very truly yours, GRI BIO, INC. /s/ W. Marc Hertz, Ph.D. W. Marc Hertz, Ph.D., Chief Executive Officer cc: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. Adam Lenain, Esq. Melanie Ruthrauff Levy, Esq. Jason Miller, Esq.